Cargando…
Metformin: a novel promising option for fertility preservation during cyclophosphamide-based chemotherapy
Cyclophosphamide (CP) could cause severe gonadotoxicity via imbalanced activation of primordial follicles through PI3K/AKT/mTOR activation. Whether metformin, a widely prescribed anti-diabetes agent with mTOR inhibitory effect, could preserve ovarian function against CP toxicity is unknown. Female C...
Autores principales: | Huang, Chu-Chun, Chou, Chia-Hung, Yang, Yu-Shih, Ho, Hong-Nerng, Shun, Chia-Tung, Wen, Wen-Fen, Chen, Shee-Uan, Chen, Mei-Jou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494485/ https://www.ncbi.nlm.nih.gov/pubmed/33543290 http://dx.doi.org/10.1093/molehr/gaaa084 |
Ejemplares similares
-
Changes in peripheral mitochondrial DNA copy number in metformin-treated women with polycystic ovary syndrome: a longitudinal study
por: Yang, Po-Kai, et al.
Publicado: (2020) -
The effect of androgens on ovarian follicle maturation: Dihydrotestosterone suppress FSH-stimulated granulosa cell proliferation by upregulating PPARγ-dependent PTEN expression.
por: Chen, Mei-Jou, et al.
Publicado: (2015) -
Divergent endometrial inflammatory cytokine expression at peri-implantation period and after the stimulation by copper intrauterine device
por: Chou, Chia-Hung, et al.
Publicado: (2015) -
Obesity alters ovarian folliculogenesis through disrupted angiogenesis from increased IL-10 production
por: Yang, Po-Kai, et al.
Publicado: (2021) -
Fertility Preservation Options After Gonadotoxic Chemotherapy
por: Hyman, Jordana Hadassah, et al.
Publicado: (2013)